Siviour pilot work and placement
During the year to 30 June 2021, a large-scale flotation pilot processed more than 70 tonnes of Siviour ore; Renascor also reported A$17.882m raised net of costs for exploration and Siviour development.
Five consolidated financial years ended 30 June 2021-2025, in Australian dollars unless a table labels shares, cents or graphite tonnes. The financial tables use current-year statement values except the identified FY2023 EPS comparative; Siviour Resource and Reserve figures are annual-report snapshots.
Reading the tables: 0 (nil) is a supported zero. Other text distinguishes an amount included in another line, a non-applicable item, a separately unavailable component and an unresolved value. These are not interchangeable. Period-specific detail is labelled; complete year-by-year detail remains available.
Consolidated statutory result; rounded from AUD 1,829,388.
Includes A$90m term deposits; balance-sheet cash line is A$15.391m.
Siviour capitalised carrying amount at 30 June 2025.
Consolidated balance sheet at 30 June 2025.
Renascor remained a graphite project developer with no revenue from products or services in these annual reports. Interest income on cash holdings was the main reported revenue line; the statutory result moved from losses in FY2021-FY2022 to modest profits in FY2023-FY2025. Capital raised through equity funded the Siviour development asset and exploration work.
The balance sheet separates on-call cash from current term deposits from FY2023. At 30 June 2025, A$90m was in term deposits and A$15.391m in cash and equivalents, while the cash-flow statement reports A$105.391m at year end. The A$185m Export Finance Australia facility was an approval milestone; the issuer stated no borrowings at 30 June 2024 or 2025.
During the year to 30 June 2021, a large-scale flotation pilot processed more than 70 tonnes of Siviour ore; Renascor also reported A$17.882m raised net of costs for exploration and Siviour development.
The 3 May 2022 placement issued 240,740,741 shares for gross A$65m. FY2022 narrative reported A$62.698m raised net of costs and a 17% increase in Indicated Resource.
The South Australian authority approved Siviour's Program for Environment Protection and Rehabilitation in November 2022, permitting planned concentrate processing up to 1.65 Mtpa; this was an approval, not operating production.
Export Finance Australia confirmed the A$185m project-loan approval on 17 April 2024; an Early Contractor Involvement process began on 24 June 2024. Neither event is represented as a drawn borrowing.
In June 2025 the South Australian planning minister granted provisional development authorisation for the planned commercial-scale battery anode material facility for up to 100,000 tonnes a year of purified spherical graphite.
Interest receipts and income dominate the reported profit path; the annual reports show no product sales. The FY2023 EPS comparative discrepancy is isolated below rather than treated as a proven restatement.
AUD
AI-generated presentation · values from Consolidated income statement, AUD; no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Interest revenue | 3,778 | 6,093 | 2,967,011 | 5,007,080 | 4,986,165 |
| Other income | 8,000 | 0 (nil) | 255 | 540 | 75,000 |
| Total revenue | 11,778 | 6,093 | 2,967,266 | 5,007,620 | 5,061,165 |
| Administration and consulting | -424,832 | -575,552 | -872,505 | -978,428 | -965,882 |
| Depreciation and amortisation | -1,823 | -4,388 | -11,074 | -119,331 | -137,761 |
| Employee benefits | -324,364 | -454,948 | -1,292,480 | -1,792,716 | -1,670,336 |
| Office accommodation | -30,596 | -30,596 | -30,597 | Not separately presented | Not separately presented |
| Impairment of exploration expenditure | 0 (nil) | -198,898 | -23,531 | -1,144 | -34,958 |
| Legal fees | -13,998 | -12,115 | -4,434 | Not separately presented | Not separately presented |
| Other expenses | -93,395 | -226,238 | -307,929 | -408,337 | -422,840 |
| Other expenses (comparable presentation) | -137,989 | -268,949 | -342,960 | -408,337 | -422,840 |
| Total expenses | -889,008 | -1,502,735 | -2,542,550 | -3,299,956 | -3,231,777 |
| Profit/(Loss) before income tax | -877,230 | -1,496,642 | 424,716 | 1,707,664 | 1,829,388 |
| Income tax expense | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) |
| Profit/(Loss) after income tax | -877,230 | -1,496,642 | 424,716 | 1,707,664 | 1,829,388 |
All amounts are reported dollars. Expense rows retain negative signs; nil tax is a source-supported nil, not a missing value.
FY2021–FY2023 original statements show office accommodation and legal fees separately from Other expenses. Their signed analytical sums with Other expenses are AUD (137,989), (268,949), and (342,960). FY2024–FY2025 columns in the added bridge are the issuer-reported unsplit Other expenses totals, AUD (408,337) and (422,840). The selected records do not establish whether or how much office/legal cost occurred or was allocated within those later totals. This is a presentation comparison, not proof of identical composition or an additional expense to add to statutory totals.
Source: Renascor Resources Limited annual reports FY2021-FY2025; each value retains its source record in the author evidence file.
Cents per share or shares, as labelled
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Basic earnings per sharecents per share | -0.1 | -0.1 | 0.02 | 0.07 | 0.07 |
| Diluted earnings per sharecents per share | -0.1 | -0.1 | 0.02 | 0.07 | 0.07 |
| Weighted average shares — basicnumber of shares | 1,617,816,869 | 1,932,584,840 | 2,369,539,586 | 2,539,803,015 | 2,542,041,801 |
| Weighted average shares — dilutednumber of shares | 1,617,816,869 | 1,932,584,840 | 2,371,392,101 | 2,548,720,502 | 2,572,860,190 |
FY2023 original income statement prints 0.2 cents for both EPS lines (R001894, R001896), while the FY2024 comparative prints 0.02 cents. The later comparative is displayed for FY2023 and the discrepancy remains recorded; no formal restatement is inferred.
Share counts are weighted averages; they are not the shares outstanding at 30 June. FY2021-FY2022 loss periods treat potential shares as anti-dilutive.
Source: Renascor Resources Limited annual reports FY2021-FY2025; each value retains its source record in the author evidence file.
The development asset rose as the company capitalised Siviour expenditure. Term deposits shifted the presentation of liquidity: the cash-flow closing line and balance-sheet cash line should be read with the separate current financial-assets row.
AUD
AI-generated presentation · values from Balance-sheet liquidity and cash-flow reconciliation, AUD; no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents on balance sheet | 17,273,801 | 74,035,061 | 89,270,091 | 80,021,761 | 15,390,842 |
| Current financial assets: term deposits | Not separately presented | Not separately presented | 40,000,000 | 30,000,000 | 90,000,000 |
| Cash and cash equivalents at end of year in cash-flow statement | 17,273,801 | 74,035,061 | 129,270,091 | 110,021,761 | 105,390,842 |
From FY2023, the cash-flow statement closing line includes term deposits also shown as separate current financial assets on the balance sheet (FY2023 AUD 40m; FY2024 AUD 30m; FY2025 AUD 90m). Do not add the two lines again.
FY2021 directors' narrative says deposits at call AUD 17,273,701, while the audited balance sheet reports cash and equivalents AUD 17,273,801 including cash on hand AUD 100. The table uses the audited balance sheet.
Source: Renascor Resources Limited annual reports FY2021-FY2025; each value retains its source record in the author evidence file.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Other receivables (current) | 109,420 | 441,106 | 2,091,236 | 2,963,800 | 1,380,881 |
| Prepayments | 67,305 | 19,891 | 128,710 | 179,702 | 156,200 |
| Total current assets | 17,450,526 | 74,496,058 | 131,490,037 | 113,165,263 | 106,927,923 |
| Property, plant and equipment | 9,559 | 11,738 | 38,395 | 11,514,115 | 12,312,929 |
| Exploration and evaluation | 1,659,037 | 1,458,671 | 1,496,007 | 1,633,840 | 1,845,182 |
| Development asset | 17,060,233 | 21,457,620 | 35,898,362 | 44,572,222 | 54,505,049 |
| Total non-current assets | 18,773,829 | 22,973,029 | 37,477,764 | 57,919,996 | 68,977,979 |
| Total assets | 36,224,355 | 97,469,087 | 168,967,801 | 171,085,259 | 175,905,902 |
| Trade and other payables (current) | 441,226 | 1,046,426 | 2,483,385 | 1,730,871 | 3,023,794 |
| Provisions (current) | 601,324 | 144,653 | 273,934 | 381,851 | 449,898 |
| Lease liabilities (current) | Not separately presented | Not separately presented | 0 (nil) | 123,704 | 461,839 |
| Total current liabilities | 1,042,550 | 1,191,079 | 2,757,319 | 2,236,426 | 3,935,531 |
| Total non-current liabilities | Not separately presented | 2,743 | 10,150 | 90,028 | 578,500 |
| Total liabilities | 1,042,550 | 1,193,822 | 2,767,469 | 2,326,454 | 4,514,031 |
| Issued capital (consolidated) | 51,903,152 | 114,601,254 | 183,825,034 | 184,073,400 | 184,255,773 |
| Reserves (consolidated) | 247,340 | 139,340 | 415,911 | 1,018,354 | 1,639,659 |
| Accumulated losses (consolidated) | -16,968,687 | -18,465,329 | -18,040,613 | -16,332,949 | -14,503,561 |
| Total equity / Net assets (consolidated) | 35,181,805 | 96,275,265 | 166,200,332 | 168,758,805 | 171,391,871 |
Balances are at 30 June of the stated year and use consolidated current-year statements where available. FY2023 original balance-sheet values were checked against the FY2024 comparative and agree for the displayed lines.
The Siviour development asset is a capitalised carrying amount, not annual cash spend. Financial assets, including term deposits, appear in the separate liquidity table.
Source: Renascor Resources Limited annual reports FY2021-FY2025; each value retains its source record in the author evidence file.
Operating cash inflow remained smaller than investment in the project and associated property, plant and equipment in FY2024-FY2025. FY2025 grant co-funding is an investing cash receipt; the larger grant award is a distinct project milestone.
AUD
AI-generated presentation · values from Consolidated cash-flow statement, AUD; no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Payments to suppliers and employees, as reported | -728,952 | -1,394,221 | -1,617,216 | -2,226,918 | -2,348,390 |
| Interest received | 3,778 | 6,093 | 1,615,260 | 4,933,453 | 5,165,806 |
| Net cash from / (used in) operating activities | -721,077 | -974,038 | 329,576 | 2,706,535 | 2,892,416 |
| Payments for property, plant and equipment | -7,703 | -6,567 | -35,097 | -10,831,167 | -91 |
| Payments for exploration and evaluation | -408,383 | -48,532 | -49,523 | -119,618 | -143,715 |
| Payments for development assets | -1,327,232 | -4,542,348 | -14,093,418 | -10,897,739 | -9,300,203 |
| Grant co-funding received (investing) | Not separately presented | Not separately presented | Not separately presented | 0 (nil) | 2,250,000 |
| Net cash used in investing activities | -1,743,318 | -4,547,447 | -14,177,783 | -21,952,803 | -7,309,009 |
| Proceeds from issue of shares | 19,205,735 | 65,913,368 | 70,000,000 | 0 (nil) | Not separately presented |
| Net cash from / (used in) financing activities | 17,882,412 | 62,282,745 | 69,083,237 | -2,062 | -214,326 |
| Net increase / (decrease) in cash and cash equivalents | 15,418,017 | 56,761,260 | 55,235,030 | -19,248,330 | -4,630,919 |
| Cash and cash equivalents at end of period | 17,273,801 | 74,035,061 | 129,270,091 | 110,021,761 | 105,390,842 |
FY2021-FY2023 statements show GST receipts/payments separately from supplier and employee payments; FY2024-FY2025 use one combined payments line. The first row has a visible basis break and must not be read as a like-for-like cost trend.
FY2025 investing inflow of AUD 2,250,000 is grant co-funding cash received; it is separate from the AUD 5m grant award described in the annual-report narrative. FY2025 financing includes AUD 212,226 lease-liability payments and AUD 2,100 capital raising costs.
Closing cash in the cash-flow statement includes term deposits from FY2023 onward; see the liquidity table.
Source: Renascor Resources Limited annual reports FY2021-FY2025; each value retains its source record in the author evidence file.
The capital base expanded through placements and option exercises, especially in FY2021-FY2023. The FY2022 share count comes from that year's issued-capital schedule. Each annual report states no dividend was paid, recommended or declared.
Siviour is the central development project. The annual-report Resource and Reserve figures are estimates of in-ground graphite and do not indicate mineral output. The issuer's FY2025 asset review concluded that the development asset was not impaired; assumptions included graphite price and USD/AUD sensitivity.
Mt
AI-generated presentation · values from Siviour graphite Resource and Reserve figures carried in each annual report; no missing values plotted as zero.
Mt or % TGC, as labelled
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total — tonnes (Proven + Probable)Mt | 51.5 | 51.5 | 51.5 | 61.8 | 61.8 |
| Total — grade% TGC | 7.4 | 7.4 | 7.4 | 7 | 7 |
| Total — contained graphiteMt contained graphite | 3.8 | 3.8 | 3.8 | 4.3 | 4.3 |
| Total — tonnes (Measured + Indicated + Inferred)Mt | 87.4 | 93.5 | 93.5 | 123.6 | 123.6 |
| Total — grade% TGC | 7.5 | 7.3 | 7.3 | 6.9 | 6.9 |
| Total — contained graphiteMt contained graphite | 6.6 | 6.9 | 6.9 | 8.5 | 8.5 |
These are geological estimate snapshots reproduced in annual reports, not production, sales or annual change. Some reports incorporate resource or reserve updates announced after the 30 June balance date; the column denotes the annual-report edition.
The FY2024 edition reflects the 2023 updated Reserve and Resource announcements; repeated values in FY2025 do not represent new production.
Source: Renascor Resources Limited annual reports FY2021-FY2025; each value retains its source record in the author evidence file.
Prepared from the existing annual extraction datasets, supplemented only by selected same-company annual-report tables and saved row interpretations. No new raw-document extraction or web financial research was used for this test.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.